| abstract |
The present invention relates to general formula (I) For the treatment of pain selected from the group consisting of acute pain, neuropathic pain, visceral pain, chronic pain and inflammatory pain. To the manufacture of effective or migraine, diabetes, respiratory disease, inflammatory bowel disease, neurological disease, septic shock, reperfusion syndrome, drugs for the treatment of obesity, and drugs as angiogenesis inhibitors It relates to the use of substituted spiroamines. |